坦布亚明的优化 活跃于对抗多个阶段的疟疾寄生虫
Amrendra Kumar1, Yuexin Li2, Xiaowei Zhang2
1Department of Chemistry, Portland State University, Portland, Oregon 97201, United States.
Journal of medicinal chemistry
|June 1, 2025
概括
新的抗疟疾药物候选药物,tambjamines,在多个生命阶段对疟疾寄生虫表现出强大的口服疗效. 化合物KAR1123治愈了小鼠的感染,并证明了对抗耐药疟疾菌株的活性.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 疟疾对全球健康构成重大威胁,需要新的抗疟疾药物来对抗寄生虫耐药性.
- 由于药物耐药性广泛蔓延,现有疗法面临挑战.
- 以天然产品为灵感的tambjamine化学型已经显示出对抗各种疟疾寄生虫阶段的承诺.
研究的目的:
- 为了优化tambjamine化学型,以提高抗疟疾活性和类似药物的特性.
- 识别具有强大的口服疗效和有利的安全性概况的化合物.
- 评估针对不同疟疾寄生虫生命阶段和耐药菌株的优化tambjamines的疗效.
主要方法:
- 化学图书馆的扩展和对tambjamine脚手架的严格优化.
- 在鼠标疟疾模型 (Plasmodium yoelii和Plasmodium berghei) 的体内疗效研究.
- 在实验室中对杀死寄生虫的动力学和对抗抗药性Plasmodium falciparum的活性进行评估.
主要成果:
- 几种优化的tambjamines显示出极好的口服疗效.
- 化合物KAR1123 (109) 在小鼠中治愈了红细胞性Plasmodium yoelii感染,并显示出对肝脏阶段的Plasmodium berghei的部分保护.
- KAR1123对抗抗美素耐药的Plasmodium falciparum和临床分离物表现出强烈的活性,具有中等快速的体外杀虫特征.
结论:
- 优化的tambjamines代表了一个有希望的口服抗疟疾药物的新类别.
- KAR1123显示出作为疟疾治疗候选药物的巨大潜力,包括耐药形式.
- 进一步开发tambjamines可以在打击疟疾方面提供一种至关重要的新工具.
更多相关视频
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
2.9K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.3K
相关概念视频
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...